Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Garris, Christopher S., Arlauckas, Sean P., Kohler, Rainer H., Trefny, Marcel P., Garren, Seth, Piot, Cécile, Engblom, Camilla, Pfirschke, Christina +15 more·2018·Immunity
Cited by (970)
Items 601–700 of 970
- New technology on the horizon: Fast analytical screening technique FNA (FAST‐FNA) enables rapid, multiplex biomarker analysis in head and neck cancersSara Isabel Pai, William C. Faquin, Peter M. Sadow, Mikaël J. Pittet, Ralph Weissleder · 2020 · Cancer Cytopathology
- Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon AdenocarcinomaAnqi Lin, Wentao Xu, Peng Luo, Jian Zhang · 2021 · Frontiers in Pharmacology
- Novel Fluorinated Spermine and Small Molecule PEI to Deliver Anti-PD-L1 and Anti-VEGF siRNA for Highly Efficient Tumor TherapyYihui Zhang, Zihan Yuan, Yi Jin, Wenkai Zhang, Weien Yuan · 2021 · Pharmaceutics
- Recent Advances in DNA Vaccines against Lung Cancer: A Mini ReviewTing Lin Huang, Li Liu, Zheng Lv, Kelei Zhao, Qiong Yi, Jing Zhang · 2022 · Vaccines
- Endogenous CD83 Expression in CD4+ Conventional T Cells Controls Inflammatory Immune ResponsesKatarina Liedtke, Christina Alter, Anne Günther, Nadine Hövelmeyer, Robert Klopfleisch, Ronald Naumann, Frank Thomas Wunderlich, Jan Buer, Astrid Maria Westendorf, Wiebke Hansen · 2020 · The Journal of Immunology
- Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in miceFunayama, Eiji, Hosonuma, Masahiro, Tajima, Kohei, Isobe, Junya, Baba, Yuta, Murayama, Masakazu, Narikawa, Yoichiro, Toyoda, Hitoshi, Tsurui, Toshiaki, Maruyama, Yuki et al. · 2025 · Biomedicine & Pharmacotherapy
- The Biology of Immune-Active Cancers and Their Regulatory MechanismsDavide Bedognetti, Alessandra Cesano, Francesco Maria Marincola, Ena Wang · 2020 · Cancer treatment and research
- Nanomaterials for Skin Cancer PhotoimmunotherapyCarlota M. Relvas, Susana Gomes Santos, María José Oliveira, Fernão Domingos Magalhães, Artur M. Pinto · 2023 · Biomedicines
- IL-12/IL-23–Independent Function of BATF3-Dependent Dendritic Cells Is Required for Initiation of Disease in a Mouse Model of VitiligoMichael L. Frisoli, Jillian M. Richmond, John E. Harris · 2024 · Journal of Investigative Dermatology
- NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent mannerJiwei Zhang, Fen Ma, Zhe Li, Yuan Li, Xun Sun, Mingxu Song, Fan Yang, Enjiang Wu, Xiaohui Wei, Zhengtao Wang et al. · 2024 · MedComm
- Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate cancerRongbin Zhou, Dingjin Lu, Junhao Mi, Chengbang Wang, Wenhao Lu, Zuheng Wang, Xiao Li, Chunmeng Wei, Huiyong Zhang, Jin Ji et al. · 2024 · Scientific Reports
- Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironmentsUm‐e‐Kalsoom, Shiqi Wang, Junle Qu, Liwei Liu · 2024 · Cancer Medicine
- Inflammatory factors collaboratively link Helicobacter pylori-induced gastritis to gastric cancerMingze Zhang, Ade Su, Houji Song, Siyu Zhang, Yuan Deng, Wutang Jing, Jin Guo, Weipeng Zhan, Yuntao Ma, Ming Hu · 2025 · Frontiers in Immunology
- Interaction of intratumoral microbiota with the tumor immune microenvironment and its impact on cancer progressionYan Tingting, Zhu Xiaoling, Yu Zhang, Yan Luo, Yang Luo, Shang Xueqin, Tang Shikai · 2025 · Frontiers in Oncology
- Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related GenesJiahao Yu, Shuoyi Ma, Siyuan Tian, Miao Zhang, Xiaopeng Ding, Yansheng Liu, Fangfang Yang, Yinan Hu, Guoyun Xuan, Xinmin Zhou et al. · 2021 · Frontiers in Cell and Developmental Biology
- A Novel Ferroptosis-Related LncRNA Pair Prognostic Signature Predicts Immune Landscapes and Treatment Responses for Gastric Cancer PatientsJiazheng Li, Renshen Xiang, Wei Song, Jing Wu, Can Kong, Tao Fu · 2022 · Frontiers in Genetics
- Acral Melanoma Is Infiltrated with cDC1s and Functional Exhausted CD8 T Cells Similar to the Cutaneous Melanoma of Sun-Exposed SkinSaraí G De León-Rodríguez, Cristina Aguilar-Flores, Julián A. Gajón, Alejandra Mantilla, Raquel Gerson-Cwilich, José Fabián Martínez‐Herrera, Benigno E. Rodríguez-Soto, Claudia Teresita Gutiérrez-Quiroz, Vadim Pérez‐Koldenkova, Samira Muñoz-Cruz et al. · 2023 · International Journal of Molecular Sciences
- Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanomaShaolong Leng, Gang Nie, Changhong Yi, Yunsheng Xu, Lvya Zhang, Linyu Zhu · 2023 · Cancer Cell International
- Fabrication of An Immunostimulatory Supramolecular Nanomedicine for Potent Cancer ChemoimmunotherapyXinyang Yu, Shaolong Qi, Fangfang Cao, Kai Yang, Hongjian Li, Kun Peng, Zhida Liu, Bing Bai, Marija Buljan, Xiaoyuan Shawn Chen et al. · 2023 · JACS Au
- Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, Antonia Resag, Zhe Fu, Markus Außerhofer, Christoph H. Tripp, Sophie Marie Dieckmann, Markus Kanduth, Kathryn J. Farrand et al. · 2024 · Journal for ImmunoTherapy of Cancer
- Protein tyrosine phosphatases: emerging role in cancer therapy resistanceMin Zhao, Wen Shuai, Zehao Su, Ping Xu, Aoxue Wang, Qiu Sun, Guan Wang · 2024 · 癌症:英文版
- Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockadeSeyed Mohammad Miri, Mir Saeed Ebrahimzadeh, Elahe Abdolalipour, Mahsa Yazdi, Hassan Hosseini Ravandi, Amir Ghaemi · 2020 · Cancer Cell International
- Identification of Subtypes and a Prognostic Gene Signature in Colon Cancer Using Cell Differentiation TrajectoriesRenshen Xiang, Jincheng Fu, Yuhang Ge, Jun Tao Ren, Wei Song, Tao Fu · 2021 · Frontiers in Cell and Developmental Biology
- The soldiers needed to be awakened: Tumor-infiltrating immune cellsWang Yaping, Zhe Wang, Chu Zhuling, Ruolei Li, Fan Pengyu, Guo Lili, Ji Cheng, Zhang Bo, Liuyin Liu, Hou Guangdong et al. · 2022 · Frontiers in Genetics
- Current “state of the art” on dendritic cell-based cancer vaccines in melanomaJulia Katharina Schwarze, Xenia Geeraerts, Sandra Tuyaerts, Bart Neyns · 2023 · Current Opinion in Oncology
- Opportunities for improving cancer treatment using systems biologyJason I. Griffiths, Adam Louis Cohen, Veronica Jones, Ravi Salgia, Jeffrey T. Chang, Andrea H. Bild · 2019 · Current Opinion in Systems Biology
- Cellular Plasticity during Metastasis: New Insights Provided by Intravital MicroscopyAndreia S. Margarido, Laura Bornes, Claire Vennin, Jacco van Rheenen · 2019 · Cold Spring Harbor Perspectives in Medicine
- Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotypeBiplab Sarkar, Sean P. Arlauckas, Michael F. Cuccarese, Christopher Garris, Ralph Weissleder, Christopher B. Rodell · 2024 · Frontiers in Immunology
- DC subsets and states unraveled across human juxtatumoral and malignant tissuesKevin Mulder, Margaux Gardet, Wan Ting Kong, Amit Ashok Patel, Anne Calvez, Grégoire Gessain, Carlos de la Calle‐Fabregat, Cécile Piot, Quentin Blampey, Elisa Poupaud et al. · 2025 · Nature Immunology
- Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric CancerXinpeng Hu, Minfeng Chen, Qiang Ruan, Changzheng Shi, Jinghua Pan, Liangping Luo · 2022 · Journal of Immunology Research
- WT1 Pulsed Human CD141+ Dendritic Cell Vaccine Has High Potential in Solid Tumor-Targeted ImmunotherapySungyoon Cho, Seong Mun Jeong, Young Joo Jeon, Sun Ja Yang, Ju Eun Hwang, Byung Moo Yoo, Hyun Soo Kim · 2023 · International Journal of Molecular Sciences
- Dendritic cell maturation in the tumor microenvironmentYuhui Miao, Yuning Liu, Haidong Tang, Zemin Zhang · 2023 · National Science Open
- Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumorsJiage Ding, Yanyan Zheng, Fei Zhu, Meng Wang, Lin Fang, Yong U. Liu, Hui Tian, Yong U. Liu, Gang Wang, Junnian Zheng et al. · 2023 · International Immunopharmacology
- DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of OncotherapyMengjie Wang, Xia Yu, Qinglei Gao · 2024 · Current Medical Science
- Construction and Validation of an Immune‐Related Gene Prognostic Index for Esophageal Squamous Cell CarcinomaQinghua Ji, Yingying Cai, Sachin Mulmi Shrestha, Duo Shen, Wei Zhao, Ruihua Shi · 2021 · BioMed Research International
- Direct and indirect engagement of dendritic cell function by antibodies developed for cancer therapyDiana Corogeanu, Sandra S. Diebold · 2022 · Clinical & Experimental Immunology
- Cancer Immunotherapy: Diverse Approaches and ObstaclesSeyed Amir Sanatkar, Arash Heidari, Nima Rezaei · 2022 · Current Pharmaceutical Design
- Immune checkpoint inhibitors combined with HER-2 targeted therapy in HER-2 positive gastroesophageal cancerAdilai Aisa, Shanshan Weng, Xinyu Li, Ding Zhang, Ying Yuan · 2022 · Critical Reviews in Oncology/Hematology
- Transcriptomic analysis of esophageal cancer reveals hub genes and networks involved in cancer progressionDipankor Chatterjee, Md. Mostafijur Rahman, Anik Kumar Saha, Mohammad Kawsar Sharif Siam, Mohammad Umer Sharif Shohan · 2023 · Computers in Biology and Medicine
- New Clones on the BlockNandini Acharya, Ana Carrizosa Anderson · 2019 · Immunity
- Teamwork by different T-cell types boosts tumour destruction by immunotherapyJonathan L. Linehan, Lélia Delamarre · 2019 · Nature
- Intratumoral mregDC and CXCL13 T helper niches enable local differentiation of CD8 T cells following PD-1 blockadeA. Magen, P. Hamon, N. Fiaschi, Leanna Troncoso, Étienne Humblin, D. D'Souza, T. Dawson, Matthew D. Park, Joel Kim, Steven Hamel et al. · 2022 · bioRxiv
- Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapyMingyong Zha, Fei Huang, Song‐Lin Li, Qi Wang, Yong Tang · 2025 · Frontiers in Oncology
- Genetically modified bacterial vesicles with interferon-γ and tumor antigen remodel anti-tumor cellular immunity by modulating dendritic cellsYuting Fu, Biao Duan, Peng Zheng, Han Chu, Weiran Li, Ying Yang, Zhongqian Yang, Jinrong He, Mengzhen Wang, Shuqin Li et al. · 2025 · Biomaterials
- Arginine Competition in Tumor Microenvironment: A Potential Target for Cancer TherapyJunlei Zhang, Sijie Wang, Huihui Liu, Lihua Luo, Jian You · 2025 · Medicinal Research Reviews
- Identity, Functions, and the Spatiotemporal Maturation of Type 1 Conventional Dendritic CellsRamazan Akyol, Marc Dalod · 2025 · Immunological Reviews
- A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in miceHaiyan Zhou, Ruiming Sun, Xiaoqun Nie, Liliang Xia, Hui Dong, Yujie Liu, Shurui Hou, Wenyue Dong, Xiaokuan Zhu, Yaxian Yao et al. · 2026 · Nature Microbiology
- Mathematical modeling identifies LAG3 and HAVCR2 as biomarkers of T cell exhaustion in melanomaRichard J. Beck, Sander Sloot, Hirokazu Matsushita, Kazuhiro Kakimi, Joost B. Beltman · 2023 · iScience
- Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditionsElisa C. Toffoli, A.A. van Vliet, C Forbes, Annemijn J. Arns, Henk M.W. Verheul, Jurriaan B. Tuynman, Hans J. van der Vliet, Jan Spanholtz, Tanja D. de Gruijl · 2024 · Clinical & Experimental Immunology
- Effector Functions of Dendritic Cells in Cancer: Role of Cytotoxicity and Growth InhibitionPratima Chaudhary, Prateek Srivastava, Partha Pratim Manna · 2024 · Frontiers in Bioscience-Landmark
- Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Chemotherapy for Advanced Pancreatic CancerDong Song, Xuejing Yang, Xin Guo, Hu Sun · 2022 · Immunotherapy
- Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell ExhaustionYasunari Fukuda, Sun-Hee Kim, Matias Alberto Bustos, Sung-Nam Cho, Jason Roszik, Jared K. Burks, Hong Kim, Dave S.�B. Hoon, Elizabeth Ann Grimm, Sühendan Ekmekçioglu · 2023 · Cancer Research Communications
- Virus‐Like Nanotherapeutic for Spatiotemporally Enhancing Antigen Presentation and Cross‐Presentation toward Potential Personalized ImmunotherapyXiaodi Li, Pengfei Yuan, Haiyuan Yang, Xiaoqing Zong, Caiqi Yang, Xinjie Chen, Yuchao Li, Xiaodie Yan, Yaoqi Wen, Tianci Zhu et al. · 2023 · Advanced Healthcare Materials
- Combination Immunotherapy Strategies in Breast CancerBrie Chun, David B. Page, Heather L. McArthur · 2019 · Current Breast Cancer Reports
- AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancerMeriem Belabed, Matthew D. Park, Cédric M. Blouin, Sreekumar Balan, Chang Yoon Moon, Jesse Boumelha, Ante Peros, Raphaël Mattiuz, Amanda M. Reid, Camillia S. Azimi et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
- Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cellsWentao Pan, Qiuyun Luo, Eric Liang, Mude Shi, Jian Sun, Huimin Shen, Zhenhai Lu, Lin Zhang, Xianglei Yan, Luping Yuan et al. · 2024 · Cancer Cell International
- Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinomaZihao Sun, Mingdao Hu, Xiaoning Huang, Minghan Song, Xiujing Chen, Jiaxin Bei, Yiguang Lin, Size Chen · 2025 · Cancer Cell International
- Rejuvenation of Tumor‐Specific T Cells via Ultrahigh DAR Antibody‐Polymeric Imidazoquinoline Complexes: Coordinated Targeting of PDL1 and Efficient TLR7/8 Activation in Intratumoral Dendritic CellsHongyu Chu, Yuezhan Shan, Zongyu Liu, Mengmeng Sun, Weidong Zhao, Xiao Xie, Kun Wang, Chenguang Yang, Xuedong Fang, Na Shen et al. · 2025 · Advanced Materials
- Sono-Destructive Polymeric Nanocapsules Enable Spatiotemporal Orchestration of DC-T Cell Crosstalk in Combined In Situ Vaccination and Cytokine TherapyWencong Jia, Wei Yang, Ye Wu, Hongze Ren, Yiwen Jia, Weifan Ye, Yujie Xie, Yu Chen, Meihua Yu · 2025 · Journal of the American Chemical Society
- PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironmentLisa A. King, Myrthe Veth, Marieke Roos, George L. Scheffer, Marko A. Popovic, Tanja D. de Gruijl, Hans J. van der Vliet · 2025 · Journal for ImmunoTherapy of Cancer
- Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1+ cDC1 infiltration and activates anti-tumor immunityLouise Gorline, Fillipe Luiz Rosa Do Carmo, Pierre Bourdely, Jérémie Bornères, Nathan Vaudiau, Aurélie Semervil, Mathias Vétillard, Aboubacar Sidiki K. Coulibaly, Natacha Jugniot, Agathe Ok et al. · 2025 · Nature Communications
- Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell CarcinomasMario Sánchez‐Canteli, Luis Juesas Iglesias, Irati Garmendia, María Otero‐Rosales, Alfonso Calvo, Mónica Álvarez‐Fernández, Aurora Astudillo, Luis M. Montuenga, Juana Maria Garcia-Pedrero, Juan Pablo Rodrigo · 2022 · International Journal of Molecular Sciences
- Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinomaWang‐Zhong Li, Shu‐Hui Lv, Guoying Liu, Nian Lu, Yaofei Jiang, Liang Hu, Wei‐Xiong Xia, Yan‐Qun Xiang, Changqing Xie, Jianxing He · 2023 · Frontiers in Immunology
- Calcium electroporation of esophageal cancer induces gene expression changes: a sub-study of a phase I clinical trialCharlotte Egeland, Lukas Balsevicius, Ismail Gögenür, Julie Gehl, Lene Bæksgaard, Rajendra Singh Garbyal, Michael Patrick Achiam · 2023 · Journal of Cancer Research and Clinical Oncology
- The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancerShuangcui Wang, Guan Zhang, Qian Cui, Yanjie Yang, Dong Wang, Aqing Liu, Ying Xia, Wentao Li, Yunhe Liu, Jianchun Yu · 2023 · Immunity Inflammation and Disease
- Injectable thermosensitive microsphere-hydrogel composite system: combined therapy of hepatocellular carcinoma by remodeling tumor immune microenvironmentJinghan Liao, Zhihua Wu, Yijie Qiu, Fangqin Xue, Ke Gong, Yi Duan, Chao Xu, Bin Liu, Jiangtao Lin, Yi Dong et al. · 2024 · Science China Materials
- Enhancing Tumor Immunity with IL-12 and PD-1 Blockade: A Strategy for Inducing Robust Central Memory T Cell Responses in Resistant Cancer ModelFentian Chen, Kaiqin Wu, Shiqi Lin, Jiaxing Cui, Xiaoqing Chen, Zhiren Zeng, Na Yuan, Mujin Fang, Xue Liu, Yuanzhi Chen et al. · 2024 · Antibodies
- LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinomaRongqi Sun, Kaixuan Liu, Si-Yuan Pan, Yuhang Ye, Ning Li, Shuangyi Chen, Xinyi Cui, Yuxi Zhang, Long Fei Chen, Jingyue Pan et al. · 2024 · Hepatology
- A lipid starvation strategy-synergized neutrophil activation for postoperative melanoma immunotherapyHongjuan Zhao, Mengya Niu, Yuxin Guo, Xiu‐Qing Li, Yinke Wang, Qianqian Jiang, Qingling Song, Yi Zhang, Lei Wang · 2025 · Journal of Controlled Release
- Membrane Encapsulated Fe3O4@MnO@cGAMP Nanocatalyst for Cancer Therapy: cGAS‐STING Immune Pathway ActivationHua Chai, Renpeng Xia, Nan Ouyang, Jingyu Yao, Jiukun Hu, Minxuan Sun, Peng Miao · 2025 · Advanced Healthcare Materials
- Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccinationDavid Repáraz, Marta Ruiz, Leyre Silva, Belén Aparicio, Josune Egea, Elizabeth Guruceaga, Daniel Ajona, Yaiza Senent, Enrique Conde, Flor C. Navarro et al. · 2022 · Frontiers in Immunology
- Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinomaManato Ohsawa, Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, Ryosuke Hirohata, Nao Kitasaki, Morihito Okada · 2023 · Frontiers in Oncology
- Roles of Fascin in Dendritic CellsHao-Jie Wang, Ya-Ping Jiang, Jun-Ying Zhang, Xiaoqi Tang, Jian-Shu Lou, Xin‐Yun Huang · 2023 · Cancers
- Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinomaYaxian Wu, Shan Xing, Yu Wang, Boyu Tian, Meng Yin Wu, Xueping Wang, Qi Huang, Xia He, Shulin Chen, Xiaohui Li et al. · 2023 · Journal for ImmunoTherapy of Cancer
- Human Microbial Transplant Restores T Cell Cytotoxicity and Anti-Tumor Response to PD-L1 Blockade in Gnotobiotic MiceJoshua N. Borgerding, Joan Shang, Graham J. Britton, Hélène Salmon, Camille Bigenwald, Barbara Maier, Samuel R. Rose, Ilaria Mogno, Alice Oliffson Kamphorst, Miriam Mérad et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
- Microbial cancer immunotherapy reprograms hematopoiesis to enhance anti-tumor immunityAndrew W. Daman, Anthony C. Antonelli, Gil Redelman‐Sidi, Lucinda Paddock, Jin‐Gyu Cheong, Leonardo F. Jurado, Anna Binyamin, Song Jiang, Dughan J. Ahimovic, Shireen Khayat et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
- Prognostic Impact of Acute and Chronic Inflammatory Interleukin Signatures in the Tumor Microenvironment of Early Breast CancerAnne-Sophie Heimes, Ina Shehaj, Katrin Almstedt, Slavomir Krajnak, Roxana Michaela Schwab, Kathrin Stewen, Antje Lebrecht, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt · 2024 · International Journal of Molecular Sciences
- Emerging insights into intravital imaging, unraveling its role in cancer immunotherapyMinfeng Yang, Shiqiang Hou, Yao Chen, Hongzhao Chen, Minjie Chu, Songbai Liu · 2025 · Cancer Immunology Immunotherapy
- Neoantigen identification and TCR-T therapy development for solid tumors: current advances and future perspectivesXinyao Zheng, Yahui Zhao, Zhihua Liu · 2025 · Journal of the National Cancer Center
- Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signallingCarlos Oscar Ontiveros, Myrna G Garcia, Clare Murray, Yilun Deng, Haiyan Bai, Christopher Tanner, Bernice Leung, Xin Li, Alvaro Souto Padron, Ryan Michael Reyes et al. · 2025 · Nature Communications
- Programmed Cell Death Protein 1 Engagement Impairs Cytoskeletal Forces and Nuclear Mechanotransduction in T CellsLingzhu Zhao, Guoqing Zhao, Jiaxin Fu, Yan Liu, Jinteng Feng, Guangjian Zhang, Feng Hua Xu, Hui Guo, Min Lin · 2025 · ACS Nano
- Ferroptosis-induced immune modulation: a new frontier in glioblastoma therapyShaik Rahaman, Divya Vohora, Ähmed Kamal · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
- miRNome targeting NF-κB signaling orchestrates macrophage-triggered cancer metastasis and recurrenceDong‐Ping Chen, Juncheng Wang, Zhengyu Liu, Pei-Lin Li, Ka‐Wo Chan, Xiang-Ning Wu, Wudexin Yao, Tingting Yao, Dong‐Ming Kuang, Wei Yuan · 2024 · Molecular Therapy
- Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancerLin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Ya‐Nan Jin, Zhenchong Xiong, Liangping Xia · 2024 · British Journal of Cancer
- Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DCDiana Dudziak, Lukas Heger, William W. Agace, Joyce Bakker, Tanja D. de Gruijl, Regine J. Dress, Charles‐Antoine Dutertre, Thomas M. Fenton, Marieke F. Fransen, Florent Ginhoux et al. · 2024 · European Journal of Immunology
- Immunometabolism of Innate Immune Cells in Gastrointestinal CancerIzabela Siemińska, Marzena Lenart · 2025 · Cancers
- Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer SubtypesTingting Qin, Shiting Li, Leanne E. Henry, Elysia Chou, Raymond G. Cavalcante, Bailey Fabiny Garb, Nisha J. D’Silva, Laura S. Rozek, Maureen A. Sartor · 2023 · Cancer Research Communications
- Ag85B-ENO146-82 therapeutic vaccines enhance anti-tumor immunity by inducing CD8+ T cells and remodeling tumor microenvironmentFengjun Liu, Huan Huang, Xiaoli Yang, Shasha Jiang, Aotian Xu, Zhongjie Yu, Jun Li, Meng Yu, Yunyang Wang, Bin Wang · 2024 · International Immunopharmacology
- IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccinesMiguel C. Sobral, Laura Cabizzosu, Shawn J. Kang, Kyle T Ruark, Alexander J. Najibi, Ryan S. Lane, Einat B. Vitner, Hamza Ijaz, Maxence O. Dellacherie, Mason T. Dacus et al. · 2024 · Proceedings of the National Academy of Sciences
- Exogenous signaling repairs defective T cell signaling inside the tumor microenvironment for better immunityCasey Moore, Joonbeom Bae, Longchao Liu, Huiyu Li, Yang‐Xin Fu, Jian Qiao · 2022 · JCI Insight
- A single-beam of light priming the immune responses and boosting cancer photoimmunotherapyYue Ling Sun, Ruyin Han, Jiangyue Wang, Yang Qin, Ziwei Ren, Xiaolan Feng, Quanhong Liu, Xiaobing Wang · 2022 · Journal of Controlled Release
- A mouse model-based screening platform for the identification of immune activating compounds such as natural products for novel cancer immunotherapiesLisa Richter, Sonja Kropp, Peter Proksch, Stefanie Scheu · 2019 · Bioorganic & Medicinal Chemistry
- Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic TumorsRiccardo Dolcetti, Alejandro López‐Soto, Jessica Dal Col · 2020 · Frontiers in Immunology
- Pembrolizumab and Ipilimumab as Second-Line Therapy for Advanced MelanomaLaura A. Huppert, ADIL I. DAUD · 2021 · Journal of Clinical Oncology
- Neutrophil regulation of immunotherapy for cancer is controlled by type II interferonShengduo Pei, Yueyun Pan, Heng Liang, Li Lei, Qirong Lin, Jiarui Mi, Jeffrey V. Ravetch, Oliver Soehnlein, Mikael C. I. Karlsson · 2026 · Immunity
- Dendritic cell-targeted liposomes for cancer immunotherapy via inhibition of aryl hydrocarbon receptorChen-Guang Zhang, Chen-Yun Yeh, Sheng-Yun Hsu, Mridula Prakash, Adrian B. Abarientos, Hsi-Ming Chiang-Hsieh, You‐Yu Lin, Christopher Llynard D. Ortiz, Lee‐Wei Yang, Pi‐Hui Liang et al. · 2025 · Journal of Nanobiotechnology
- Dual-sensitization nanoformulation combining glutamine metabolism inhibition and Fas/FasL activation for enhanced colorectal cancer immunotherapyDan Yan, Wenzhe Yi, Ting Wu, Shuangshuang Hu, Yan Ding, Xindi Qian, Zhiwen Zhao, Dangge Wang, Huae Xu, Ying Cai et al. · 2025 · Journal of Controlled Release
- Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an updateJianan Lu, Jiangnan Yu, Tao Xu, Yina Li, Shuxian Chen, Qian Zhou, Lei Wang · 2025 · Cancer Drug Resistance
- Reframing adjuvant immunotherapy in melanoma: all of it starts with primingPaolo A. Ascierto, Ignacio Melero · 2025 · Journal for ImmunoTherapy of Cancer
- From Cell Death and Activation to Paralysis: Dysregulated Conventional Dendritic Cells in SIRS , Sepsis and Major Trauma Promote ImmunosuppressionMitra Ashayeripanah, Antoine Roquilly, Jóse A. Villadangos · 2026 · Immunological Reviews